Acute disseminated encephalomyelitis (ADEM) is a demyelinating central nervous system disease that is associated with high morbidity and mortality. Although the recognition of ADEM may be facilitated by newer imaging techniques, the optimal treatment of this disease remains uncertain. We describe 4
Plasmapheresis in acute disseminated encephalomyelitis
β Scribed by Chin-Hsien Lin; Jiann-Shing Jeng; Ping-Keung Yip
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 299 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Highβdose corticosteroid administration has been regarded as the main therapy for acute disseminated encephalomyelitis (ADEM). However, some patients with ADEM do not respond well to this treatment. We successfully used plasmapheresis to treat 2 patients who had ADEM. We also compared our patients' symptoms and clinical outcomes to those from previous reports. Plasmapheresis may be indicated not only for severe cases that fail to improve after highβdose corticosteroid treatment but also for firstβline treatment. Additional large, controlled, doubleβblinded trials are needed to clarify the role of plasmapheresis in ADEM. J Clin. Apheresis 19:154β159, 2004. Β© 2004 WileyβLiss, Inc.
π SIMILAR VOLUMES
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease of the central nervous system that is associated with significant morbidity and mortality. Early recognition of the disease is of paramount importance; however, treatment options are limited because only case reports and small se